Abstract:Background Arterial macrophages play an important role in atherosclerosis, exhibiting heterogeneity in their origins as either resident or inflammatory monocyte-derived macrophages. Resident macrophages originate predominantly from the yolk sac, and they are endowed with homeostatic functions and can have anti-inflammatory properties under inflammation [1]. Resident macrophages pre-existing within the tissue differentiate into foamy macrophages before monocytes appear in early atherosclerotic lesions [2]. Galectin-3 (Gal-3) encoded by the gene Lgals3, is a crucial effector molecule that is prominently expressed by macrophages [3]. Studies have provided conflicting evidence regarding the role of Gal-3 in atherosclerosis by affecting macrophage functions and monocyte recruitment [4,5]. Purpose This study aims to investigate the role of Gal-3 in arterial resident macrophages for atherosclerosis and reveal the underlying mechanisms. Methods General Lgals3 knockout (Lgals3-/-) and resident macrophage specific knockout (Lgals3-/-Rank-Cretg) mice on the Apoe-deficient background were generated and atherosclerotic lesion development (8 weeks of western diet) was compared. Results Our study revealed that Lgals3-/- mice exhibited increased numbers of monocytes and neutrophils in the blood, which was associated with the development of larger atherosclerotic plaques. Plasma Gal-3 concentration from Lgals3-/-Rank-Cretg mice was decreased by 60%, indicating that the majority of circulating Gal-3 is derived from resident macrophages. Surprisingly, Lgals3-/-Rank-Cretg mice did not show the observed increase in blood monocytes and neutrophils, suggesting that this effect was independent of circulating Gal-3. Consistent with a causal role of monocytosis and leukocytosis in atherogenesis, plaque formation in Lgals3-/-Rank-Cretg was not significantly affected. Additionally, Gal-3 deficiency promoted M1 polarization and reduced efferocytosis, phagocytosis and chemokine receptor expression in BMDMs, and the addition of exogenous Gal-3 restored the effect on phagocytosis and blocked CXCL12 and CCL5-induced leukocyte migration. Conclusion This study reveals a prominent protective role of Gal-3, primarily through inflammatory macrophages rather than resident macrophages for the development of atherosclerotic lesions. This protective effect is attributed to its homeostatic effects on monocyte and neutrophil numbers, as well as its influence on macrophage functions.

Galectin‐3 Exacerbates Ox‐ldl‐mediated Endothelial Injury by Inducing Inflammation Via Integrin Β1‐rhoa‐jnk Signaling Activation

Galectin-3 regulates inflammasome activation in cholestatic liver injury.

Galectin-3 down-regulates antioxidant peroxiredoxin-4 in human cardiac fibroblasts: a new pathway to induce cardiac damage

Galectin-3-centered Paracrine Network Mediates Cardiac Inflammation and Fibrosis Upon Β-Adrenergic Insult

Role of Galectin-3 in resident macrophages and effects on atherosclerosis

Cardiac-deleterious role of galectin-3 in chronic angiotensin II-induced hypertension

Galectin-3 Impairs Calcium Transients and Β-Cell Function

Galectin-3 Mediates Endothelial-to-Mesenchymal Transition in Pulmonary Arterial Hypertension

Galectin-3 Contributes To Vascular Fibrosis In Monocrotaline-Induced Pulmonary Arterial Hypertension Ratmodel

YAP-galectin-3 Signaling Mediates Endothelial Dysfunction in Angiotensin II-induced Hypertension in Mice.

Galectin-3 is involved in inflammation and fibrosis in arteriogenic erectile dysfunction via the TLR4/MyD88/NF-κB pathway

Galectin-3 Inhibition Attenuates Doxorubicin-Induced Cardiac Dysfunction by Upregulating the Expression of Peroxiredoxin-4

Galectin-3-induced Oxidized Low-Density Lipoprotein Promotes the Phenotypic Transformation of Vascular Smooth Muscle Cells

Effects of galectin-3 on growth, migration and inflammation of endothe-lial cells

Galectin-3 Mediates Pulmonary Vascular Remodeling in Hypoxia-Induced Pulmonary Arterial Hypertension

Galangin reduces vascular endothelial cell dysfunction via Heme oxygenase-1 signaling

Effect of galectin-3 on synovial inflammation in knee osteoarthritis via stimulating phosphatidylinositol-3-kinase/Akt pathway

Galectin-3 in Cardiovascular Diseases

BAS/BSCR26 Histone Deacetylase 3 Protects Endothelial Cells from Inflammation Via Regulation of Galectin 9 Expression

Galectin-3 Mediates Endotoxin Internalization and Caspase-4/11 Activation in Tubular Epithelials and Macrophages During Sepsis and Sepsis-Associated Acute Kidney Injury

Galectin-3 contributes to pathogenesis of IgA nephropathy